BIOCRYST PHARMACEUTICALS INC. BCRX (NASDAQ)

$ 1.68

01/07/2009 20:09

Sponsored by

Change: -0.01 (-0.59%)
Volume: 23,100

Avg. Volume:	88720
P/E Ratio:	0
EPS (Annual):	-0.97
Profit Margin:
Dividend & Yield(Annual):	0%
Shares Outstanding:	38,250
Institutional Shareholders:	50.41%

Last:	1.68
Change:	-0.01 (-0.59%)
Prev. Close:	1.69
Open:	1.60
Day's Range:	1.60 - 1.69
52wk Range:	0.85 - 6.53
Market Value:	63,130
Beta:	1.6

12-month EPS Change:	-19.17%
Total Return Last 12 Months:	-70.96%
Total Return Last 3 Years:	-307.22%
Total Return Last 5 Years:	-74.08%
5-Year Revenue Growth Rate:	3915.67%
5-Year Dividend Growth Rate:	0.00%
5-Year EPS Growth Rate:	-7.29%

Headlines on BCRX

Alert me

BioCryst shares rise as flu drug hits study goal

(BIRMINGHAM, Ala.)Shares of drug developer BioCryst Pharmaceuticals Inc. jumped Monday after the company said an injectible version of its experimental seasonal flu drug met a midstage study goal of...READ MORE

Jul 28, 2008 7:10PM

Keywords: BCRX

Movers roundup: Hasbro, Orbitz

Among the stock activity stories for Monday, July 28, from AP Financial News: NEW YORK (AP)--Shares of Hasbro Inc. fell on Monday, after an analyst said the toy maker's shares were...READ MORE

Jul 28, 2008 2:42PM

Keywords: HAS, BCRX, MHS, ESRX, SFLY